Prishna Martinez
Cell-Free DNA Methylation as a Biomarker of Malignant vs. Benign Lung Nodules: Cross-Validation of 2022 and 2023 Patient Cohorts
Cell-Free DNA Methylation as a Biomarker of Malignant vs. Benign Lung Nodules: Cross-Validation of 2022 and 2023 Patient Cohorts
Cell-Free DNA Methylation as a Biomarker of Malignant vs. Benign Lung Nodules: Cross-Validation of 2022 and 2023 Patient Cohorts